Literature DB >> 35366103

Isolation, characterization, and comparative genomic analysis of vB_PlaM_Pd22F, a new bacteriophage of the family Myoviridae.

Arif Bozdeveci1, Merve Karali1, Rahşan Akpinar2, Şengül Alpay Karaoğlu3.   

Abstract

The use of phage and phage-based products for the prevention and treatment of bee disease is one of the promising natural alternatives to chemical or antibiotic treatments in beekeeping. A novel lysogenic bacteriophage, phage Pd22F (vB_PlaM_Pd22F), was isolated from Paenibacillus dendritiformis by the prophage induction method. This phage, which is capable of infecting Paenibacillus larvae and P. dendritiformis strains, was characterized by microbiological and comparative genomic analysis. Transmission electron microscopy images showed that phage Pd22F had the morphology of a myovirus. Whole-genome sequencing results showed that vB_Pla M_Pd22F has an 86,388-bp linear dsDNA genome with a GC content of 50.68%. This genome has 124 coding sequences (CDSs), 53% of which encode functionally unknown proteins and 57 of which encode proteins that show similarity to known proteins. In addition, one tRNA gene was found. The phage Pd22F genome does not contain any antimicrobial resistance genes. The similarity between the genome sequence of phage Pd22F and the whole genome sequences of other Paenibacillus phages available in the NCBI Virus Database was found to be below 50% (42%), indicating that phage Pd22F differs greatly from previously characterized phages at the DNA level. The results of comparative genomics and phylogenetic analysis revealed that Pd22F is a new phage belonging to the family Myoviridae, order Caudovirales. This is the first report of genomic and morphological characterization of a Paenibacillus dendritiformis prophage.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Mesh:

Year:  2022        PMID: 35366103     DOI: 10.1007/s00705-022-05429-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.685


  73 in total

Review 1.  The Curious Case of Achromobacter eurydice, a Gram-Variable Pleomorphic Bacterium Associated with European Foulbrood Disease in Honeybees.

Authors:  Silvio Erler; Oleg Lewkowski; Anja Poehlein; Eva Forsgren
Journal:  Microb Ecol       Date:  2017-06-21       Impact factor: 4.552

Review 2.  American Foulbrood in honeybees and its causative agent, Paenibacillus larvae.

Authors:  Elke Genersch
Journal:  J Invertebr Pathol       Date:  2009-11-11       Impact factor: 2.841

Review 3.  Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.

Authors:  Nina Chanishvili
Journal:  Curr Drug Deliv       Date:  2016       Impact factor: 2.565

4.  Periodic reversals in Paenibacillus dendritiformis swarming.

Authors:  Avraham Be'er; Shinji K Strain; Roberto A Hernández; Eshel Ben-Jacob; E-L Florin
Journal:  J Bacteriol       Date:  2013-04-19       Impact factor: 3.490

5.  Electroactivity of the Gram-positive bacterium Paenibacillus dendritiformis MA-72.

Authors:  Yolina Hubenova; Eleonora Hubenova; Mario Mitov
Journal:  Bioelectrochemistry       Date:  2020-08-08       Impact factor: 5.373

Review 6.  European foulbrood in honey bees.

Authors:  Eva Forsgren
Journal:  J Invertebr Pathol       Date:  2009-12-21       Impact factor: 2.841

7.  Complete Genome Sequence of the Broad-Host-Range Paenibacillus larvae Phage phiIBB_Pl23.

Authors:  Ana Oliveira; Luís D R Melo; Andrew M Kropinski; Joana Azeredo
Journal:  Genome Announc       Date:  2013-09-05

8.  An Alternative Cure: The Adoption and Survival of Bacteriophage Therapy in the USSR, 1922-1955.

Authors:  Dmitriy Myelnikov
Journal:  J Hist Med Allied Sci       Date:  2018-10-01       Impact factor: 2.088

9.  Swarming and complex pattern formation in Paenibacillus vortex studied by imaging and tracking cells.

Authors:  Colin J Ingham; Eshel Ben Jacob
Journal:  BMC Microbiol       Date:  2008-02-25       Impact factor: 3.605

Review 10.  A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Authors:  Xavier Wittebole; Sophie De Roock; Steven M Opal
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.